JEONJINBIO Co., Ltd.
KKRX:1100202,060.00
KRW
-30.00
(-1.44%)
ISIN
KR7110020005
Return %
Stock
S&P 500
1Y
-26.56
13.14
3Y
-74.72
80.78
5Y
-60.08
67.74
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- CEO
- Tae-Hoon Lee
- Full Time Employees
- 30
- Sector
- Process industries
- Industry
- Chemicals: specialty
- Address
- Daegu South Korea
- IPO Date
- Dec 14, 2018
- Website
- jjbio.co.kr
- Similar Companies
- Business
- JEONJINBIO Co., Ltd. is a South Korea-based biotechnology and chemical manufacturing company specializing in the research, development, and commercialization of natural active material-based repellents, eco-friendly pest control solutions, and household chemical products. Founded in 2004 and headquartered in Daegu, South Korea, the company operates across two principal business divisions: Wildlife and Pest Damage Prevention, and Household and Home Care Products. The company utilizes a proprietary natural materials library and formulation technologies to manufacture and distribute sensory-based bio-repellents and specialty consumer goods. Its core product portfolio comprises bird repellents marketed under the To Nature Bird Free and Dr. Bird brands for agricultural, architectural, and industrial facility protection; mammal and rodent repellents formulated to prevent crop damage and infrastructure disruption from wild boars, deer, and rodents; veterinary and aquatic pest control solutions designed for livestock and aquaculture parasite management; unit-dose liquid capsule laundry detergents marketed under the Wash & Wish brand as well as custom private-label OEM and ODM production; and household deodorizers, air fresheners, and fabric mists under the Paris 16e and Bridcan brands. JEONJINBIO supplies agricultural cooperatives, industrial facility operators, municipal bodies, and consumer retail channels across South Korea, while exporting patented repellent formulations and home care products to international markets including the United States, Japan, and Europe. In recent corporate developments, JEONJINBIO has pivoted its core revenue generation toward its high-capacity automated capsule detergent manufacturing operations, expanding domestic and global OEM and ODM supply agreements. The company also experienced significant corporate restructuring and governance changes following the termination of a controlling equity transfer agreement with Dabin B&S due to counterparty financing defaults, leading to the withdrawal of associated third-party share placements and convertible bond financing plans. Following the transaction cancellation, the company has focused on resolving internal management litigation, stabilizing boardroom governance, and optimizing capital allocation to drive growth across its automated household care manufacturing lines and eco-friendly bio-repellent pipeline.